Amylyx Pharmaceuticals, Inc.
← Back to AMLX Overview

Amylyx Pharmaceuticals, Inc. (AMLX)

Profitability & Net Margin History

Current Net Margin

Amylyx Pharmaceuticals, Inc. currently has a net profit margin of .

Financial Fundamentals

AMLXQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.00-0.03
2025-09-300.00-0.03
2025-06-300.00-0.04
2025-03-310.00-0.04
2024-12-31-0.00-0.045646.02%2312294
2024-09-300.00-0.07-17476.92%2458347
2024-06-30-0.00-0.077106.55%724056
2024-03-310.09-0.12-134.01%13838
2023-12-310.110.004.36%1598
2023-09-300.100.0220.35%213
2023-06-300.100.0222.47%2027
2023-03-310.070.002.20%19733
2022-12-310.02-0.04-195.13%1538632
2022-09-300.00-0.05-15581.45%
2022-06-300.00-0.05
2022-03-310.00-0.05
2021-12-310.00-0.03
2021-09-300.00-0.02
2021-06-300.00-0.02
2021-03-310.00-0.01
2020-12-310.00-0.01

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.